Nanotechnology for In vivo Targeted siRNA Delivery

被引：30
作者：
Dahlman, James E. [1 ,2 ,4 ]
Kauffman, Kevin J. [3 ,4 ]
Langer, Robert [1 ,2 ,3 ,4 ]
Anderson, Daniel G. [1 ,2 ,3 ,4 ]
机构：
[1] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA
[2] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA
[3] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[4] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
来源：
NONVIRAL VECTORS FOR GENE THERAPY LIPID- AND POLYMER-BASED GENE TRANSFER | 2014年 / 88卷
关键词：
LIPID-LIKE MATERIALS; RNAI THERAPEUTICS; SYSTEMIC DELIVERY; DRUG-DELIVERY; ASIALOGLYCOPROTEIN RECEPTOR; NANOPARTICLES; GENE; INTERFERENCE; POTENT; VITRO;
D O I：
10.1016/B978-0-12-800148-6.00003-1
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Small interfering RNAs (siRNAs) can specifically inhibit gene expression. As a result, they have tremendous scientific and clinical potential. However, the use of these molecules in patients and animal models has been limited by challenges with delivery. Intracellular RNA delivery is difficult; it requires a system that protects the siRNA from degradative nucleases in the bloodstream, minimizes clearance by the reticuloendothelial system, maximizes delivery to the target tissue, and promotes entry into, and out of, an endocytic vesicle. Despite these barriers, recent data suggest that RNA may be targeted to cells of interest in vivo. Herein we outline strategies for targeted siRNA delivery, and describe how these strategies may be improved.
引用
收藏
页码：37 / 69
页数：33
相关论文
共 97 条
  • [1] Mechanisms of endothelial cell heterogeneity in health and disease
    Aird, WC
    [J]. CIRCULATION RESEARCH, 2006, 98 (02) : 159 - 162
  • [2] Phenotypic heterogeneity of the endothelium II. Representative vascular beds
    Aird, William C.
    [J]. CIRCULATION RESEARCH, 2007, 100 (02) : 174 - 190
  • [3] A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
    Akinc, Akin
    Zumbuehl, Andreas
    Goldberg, Michael
    Leshchiner, Elizaveta S.
    Busini, Valentina
    Hossain, Naushad
    Bacallado, Sergio A.
    Nguyen, David N.
    Fuller, Jason
    Alvarez, Rene
    Borodovsky, Anna
    Borland, Todd
    Constien, Rainer
    de Fougerolles, Antonin
    Dorkin, J. Robert
    Jayaprakash, K. Narayanannair
    Jayaraman, Muthusamy
    John, Matthias
    Koteliansky, Victor
    Manoharan, Muthiah
    Nechev, Lubomir
    Qin, June
    Racie, Timothy
    Raitcheva, Denitza
    Rajeev, Kallanthottathil G.
    Sah, Dinah W. Y.
    Soutschek, Juergen
    Toudjarska, Ivanka
    Vornlocher, Hans-Peter
    Zimmermann, Tracy S.
    Langer, Robert
    Anderson, Daniel G.
    [J]. NATURE BIOTECHNOLOGY, 2008, 26 (05) : 561 - 569
  • [4] Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
    Akinc, Akin
    Querbes, William
    De, Soma
    Qin, June
    Frank-Kamenetsky, Maria
    Jayaprakash, K. Narayanannair
    Jayaraman, Muthusamy
    Rajeev, Kallanthottathil G.
    Cantley, William L.
    Dorkin, J. Robert
    Butler, James S.
    Qin, LiuLiang
    Racie, Timothy
    Sprague, Andrew
    Fava, Eugenio
    Zeigerer, Anja
    Hope, Michael J.
    Zerial, Marino
    Sah, Dinah W. Y.
    Fitzgerald, Kevin
    Tracy, Mark A.
    Manoharan, Muthiah
    Koteliansky, Victor
    de Fougerolles, Antonin
    Maier, Martin A.
    [J]. MOLECULAR THERAPY, 2010, 18 (07) : 1357 - 1364
  • [5] Development of Lipidoid-siRNA Formulations for Systemic Delivery to the Liver
    Akinc, Akin
    Goldberg, Michael
    Qin, June
    Dorkin, J. Robert
    Gamba-Vitalo, Christina
    Maier, Martin
    Jayaprakash, K. Narayanannair
    Jayaraman, Muthusamy
    Rajeev, Kallanthottathil G.
    Manoharan, Muthiah
    Koteliansky, Victor
    Roehl, Ingo
    Leshchiner, Elizaveta S.
    Langer, Robert
    Anderson, Daniel G.
    [J]. MOLECULAR THERAPY, 2009, 17 (05) : 872 - 879
  • [6] Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
    Aleku, Manuela
    Schulz, Petra
    Keil, Oliver
    Santel, Ansgar
    Schaeper, Ute
    Dieckhoff, Britta
    Janke, Oliver
    Endruschat, Jens
    Durieux, Birgit
    Roeder, Nadine
    Loeffler, Kathrin
    Lange, Christian
    Fechtner, Melanie
    Moepert, Kristin
    Fisch, Gerald
    Dames, Sibylle
    Arnold, Wolfgang
    Jochims, Karin
    Giese, Klaus
    Wiedenmann, Bertram
    Scholz, Arne
    Kaufmann, Joerg
    [J]. CANCER RESEARCH, 2008, 68 (23) : 9788 - 9798
  • [7] Liposomal drug delivery systems: From concept to clinical applications
    Allen, Theresa M.
    Cullis, Pieter R.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) : 36 - 48
  • [8] Alnylam, 2013, RNAI THER US CONJ DE
  • [9] Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles
    Bartlett, Derek W.
    Davis, Mark E.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2008, 99 (04) : 975 - 985
  • [10] Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells
    Basha, Genc
    Novobrantseva, Tatiana I.
    Rosin, Nicole
    Tam, Yuen Yi C.
    Hafez, Ismail M.
    Wong, Matthew K.
    Sugo, Tsukasa
    Ruda, Vera M.
    Qin, June
    Klebanov, Boris
    Ciufolini, Marco
    Akinc, Akin
    Tam, Ying K.
    Hope, Michael J.
    Cullis, Pieter R.
    [J]. MOLECULAR THERAPY, 2011, 19 (12) : 2186 - 2200
12345678910